JFG
Jefferies Financial Group Portfolio holdings
AUM
$6.06B
1-Year Return
9.37%
This Quarter Return
-0.67%
1 Year Return
+9.37%
3 Year Return
+16.02%
5 Year Return
+51.04%
10 Year Return
+258.41%
AUM
$4.01B
AUM Growth
-$679M
(-14%)
Cap. Flow
-$971M
Cap. Flow
% of AUM
-24.2%
Top 10 Holdings %
Top 10 Hldgs %
27.36%
Holding
1,562
New
316
Increased
291
Reduced
291
Closed
368
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$102M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$51.6M |
| 3 |
Apple
AAPL
|
$38.9M |
| 4 |
Axsome Therapeutics
AXSM
|
$38.7M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$37.1M |
Top Sells
| 1 |
Allstate
ALL
|
$287M |
| 2 |
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
$47.3M |
| 3 |
Liberty Media Series A
FWONA
|
$40.5M |
| 4 |
SPDR Portfolio Aggregate Bond ETF
SPAB
|
$37.6M |
| 5 |
Liberty Broadband Class C
LBRDK
|
$34.4M |
Sector Composition
| 1 | Healthcare | 14.75% |
| 2 | Technology | 11.79% |
| 3 | Industrials | 10.01% |
| 4 | Consumer Discretionary | 6.33% |
| 5 | Energy | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
GSK
GSK
$81.5B
| $852K | 0.01% |
+23,503
| New | +$852K |
|
477
Alnylam Pharmaceuticals
ALNY
$59.2B
| $846K | 0.01% |
4,778
-5,129
| -52% | -$908K |
|
478
Nucor
NUE
$33.8B
| $835K | 0.01% |
5,339
-5,711
| -52% | -$893K |
|
479
FedEx
FDX
$53.7B
| $833K | 0.01% |
3,145
-11,479
| -78% | -$3.04M |
|
480
CONMED
CNMD
$1.7B
| $832K | 0.01% |
8,252
+6,113
| +286% | +$616K |
|
481
Ares Capital
ARCC
$15.8B
| $832K | 0.01% |
42,725
+36,387
| +574% | +$708K |
|
482
Helen of Troy
HELE
$587M
| $827K | 0.01% |
7,093
+1,167
| +20% | +$136K |
|
483
CDW
CDW
$22.2B
| $824K | 0.01% |
4,086
+2,339
| +134% | +$472K |
|
484
Cadence Design Systems
CDNS
$95.6B
| $820K | 0.01% |
3,500
-2,150
| -38% | -$504K |
|
485
Carlyle Group
CG
$23.1B
| $819K | 0.01% |
+27,155
| New | +$819K |
|
486
EnerSys
ENS
$3.89B
| $814K | 0.01% |
8,600
| – | – |
|
487
Palo Alto Networks
PANW
$130B
| $811K | 0.01% |
6,918
+3,454
| +100% | +$405K |
|
488
AstraZeneca
AZN
$253B
| $811K | 0.01% |
11,970
-28,127
| -70% | -$1.9M |
|
489
RAPT Therapeutics
RAPT
$214M
| $810K | 0.01% |
6,092
| – | – |
|
490
SPDR Gold Trust
GLD
$112B
| $810K | 0.01% |
4,723
+250
| +6% | +$42.9K |
|
491
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| $810K | 0.01% |
21,331
-16,832
| -44% | -$639K |
|
492
NOV
NOV
$4.95B
| $808K | 0.01% |
38,639
-317,794
| -89% | -$6.64M |
|
493
iQIYI
IQ
$2.61B
| $800K | 0.01% |
+168,801
| New | +$800K |
|
494
Pentair
PNR
$18.1B
| $796K | 0.01% |
+12,300
| New | +$796K |
|
495
Trade Desk
TTD
$25.5B
| $791K | 0.01% |
10,122
-24,262
| -71% | -$1.9M |
|
496
BlackRock Flexible Income ETF
BINC
$11.6B
| $788K | 0.01% |
+15,617
| New | +$788K |
|
497
Sprott Uranium Miners ETF
URNM
$1.68B
| $778K | 0.01% |
+16,502
| New | +$778K |
|
498
Glaukos
GKOS
$5.39B
| $776K | 0.01% |
+10,311
| New | +$776K |
|
499
Alcon
ALC
$39.6B
| $775K | 0.01% |
+10,002
| New | +$775K |
|
500
Itron
ITRI
$5.51B
| $772K | 0.01% |
12,748
-1,892
| -13% | -$115K |
|